News and Trends 3 Oct 2014
A new way to develop therapeutic monoclonal antibodies against Cancer
Up to now, a vast majority of antibodies targets proteins. Why not targeting something else? ImmuSmol, a start-up based in Bordeaux South of France is developing monoclonal antibodies against small molecules involved in tumor immune escape. This French start-up has just raised €500k to complete its preclinical proof-of-concept. Bordeaux is one of the biggest wine […]